Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityNo recent work listed

Duiyue Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5089924762. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

  1. Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A. Co-author DOI 10.3892/ijo.2020.5120↗
  2. Polysaccharide enhanced NK cell cytotoxicity against pancreatic cancer via TLR4/MAPKs/NF-κB pathway in vitro/vivo. Co-author DOI 10.1016/j.carbpol.2019.115223↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changlin Zhou · 2 shared papers, 2019–2020 · strength 0.22
  2. Yiran Zhou · 2 shared papers, 2019–2020 · strength 0.22
  3. Shuyang Pang · 1 shared paper, 2020 · strength 0.12
  4. Baiyong Shen · 1 shared paper, 2020 · strength 0.12
  5. Xin Xie · 1 shared paper, 2019 · strength 0.10
  6. Baiyong Shen · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.